0023-0042 : Tazorac 1 mg/g Cutaneous Gel


NDC: 0023-0042
Labeler: Allergan, Inc.
Product Type: Human Prescription Drug
Drug Name:  Tazorac
Dosage Form: Cutaneous Gel
Application #: NDA020600
Rev. Date: 


NDC Package Codes:

  • 0023-0042-03: 1 TUBE IN 1 CARTON (0023‑0042‑03) > 30 G IN 1 TUBE
  • 0023-0042-10: 1 TUBE IN 1 CARTON (0023‑0042‑10) > 100 G IN 1 TUBE
  • 0023-0042-15: 15 TUBE IN 1 CARTON (0023‑0042‑15) > 3.5 G IN 1 TUBE

Active Ingredients:

  • Tazarotene

Dosage Strength:

  • 1 mg/g

Pharmaceutical Classes:

  • Retinoid [EPC]
  • Retinoids [CS]

Related Products:

Based on records with the same trade name.
  • 0023-3090 Tazorac 1 mg/g Cutaneous Gel by Allergan, Inc.
  • 0023-3091 Tazorac .5 mg/g Cutaneous Gel by Allergan, Inc.
  • 0023-8335 Tazorac .5 mg/g Cutaneous Gel by Allergan, Inc.
  • 0023-9155 Tazorac .5 mg/g Cutaneous Cream by Allergan, Inc.
  • 0023-9156 Tazorac 1 mg/g Cutaneous Cream by Allergan, Inc.
  • 16110-042 Tazorac 1 mg/g Cutaneous Gel by Almirall, LLC
  • 16110-833 Tazorac .5 mg/g Cutaneous Gel by Almirall, LLC
  • 16110-915 Tazorac .05 mg/g Cutaneous Cream by Almirall, LLC
  • 16110-916 Tazorac .1 mg/g Cutaneous Cream by Almirall, LLC
  • 54868-4456 Tazorac 1 mg/g Oral Gel by Physicians Total Care, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0023-0042 QR Code

< Prev: 0019-N602Next: 0023-0066 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.